111 related articles for article (PubMed ID: 26331953)
1. A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.
Icick R; Peoc'h K; Karsinti E; Ksouda K; Hajj A; Bloch V; Prince N; Mouly S; Bellivier F; Lépine JP; Laplanche JL; Vorspan F
Am J Addict; 2015 Oct; 24(7):613-20. PubMed ID: 26331953
[TBL] [Abstract][Full Text] [Related]
2. OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients.
Icick R; Peoc'h K; Ksouda K; Bloch V; Laplanche JL; Lépine JP; Bellivier F; Vorspan F
Psychiatry Res; 2014 Aug; 218(1-2):259-60. PubMed ID: 24813900
[No Abstract] [Full Text] [Related]
3. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
4. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
5. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
[TBL] [Abstract][Full Text] [Related]
6. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI
J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696
[TBL] [Abstract][Full Text] [Related]
7. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
8. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
Nordmann S; Lions C; Vilotitch A; Michel L; Mora M; Spire B; Maradan G; Morel A; Roux P; Carrieri MP;
Psychopharmacology (Berl); 2016 Apr; 233(7):1203-13. PubMed ID: 26753792
[TBL] [Abstract][Full Text] [Related]
9. Association between HTR1B alleles and suicidal ideation in individuals with major depressive disorder.
Kao WT; Yang MC; Lung FW
Neurosci Lett; 2017 Jan; 638():204-210. PubMed ID: 28007644
[TBL] [Abstract][Full Text] [Related]
10. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
[TBL] [Abstract][Full Text] [Related]
11. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
[TBL] [Abstract][Full Text] [Related]
13. Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population.
Li H; Luo X; Ke X; Dai Q; Zheng W; Zhang C; Cassidy RM; Soares JC; Zhang X; Ning Y
PLoS One; 2017; 12(10):e0186143. PubMed ID: 29016669
[TBL] [Abstract][Full Text] [Related]
14. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
Liu CC; Fang CP; Liu TH; Kuo HW; Liu SC; Wang SC; Chen ACH; Liu YL
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():92-98. PubMed ID: 29330135
[TBL] [Abstract][Full Text] [Related]
15. A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder.
Yin H; Pantazatos SP; Galfalvy H; Huang YY; Rosoklija GB; Dwork AJ; Burke A; Arango V; Oquendo MA; Mann JJ
Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):414-426. PubMed ID: 26892569
[TBL] [Abstract][Full Text] [Related]
16. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.
Teoh Bing Fei J; Yee A; Habil MH
Am J Addict; 2016 Jan; 25(1):49-55. PubMed ID: 26692463
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological performance of methadone-maintained opiate users.
Wang GY; Wouldes TA; Kydd R; Jensen M; Russell BR
J Psychopharmacol; 2014 Aug; 28(8):789-99. PubMed ID: 24920133
[TBL] [Abstract][Full Text] [Related]
19. Somatic Comorbidity and Other Factors Related to Suicide Attempt Among Polish Methadone Maintenance Patients.
Fudalej S; Ilgen M; Kołodziejczyk I; Podgórska A; Serafin P; Barry K; Wojnar M; Blow FC; Bohnert A
J Addict Med; 2015; 9(6):433-9. PubMed ID: 26335004
[TBL] [Abstract][Full Text] [Related]
20. Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.
Baek JH; Heo JY; Fava M; Mischoulon D; Nierenberg A; Hong JP; Roh S; Jeon HJ
J Affect Disord; 2015 Nov; 187():183-7. PubMed ID: 26342171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
